Related Experiment Videos
Evaluation of the methodological quality of two contradictory guidelines recently published by the Haute autorité de
Joseph Watine1, Julien Wils2, Christine Augereau3
1Laboratoire de biologie polyvalente, Hôpital général, Villefranche-de-Rouergue, France.
Insights
Two French guidelines on vitamin D testing in chronic kidney disease patients contradict recommendations. A quality assessment suggests the 2013 guideline is more rigorously developed and has higher editorial independence than the 2012 guideline.
Area of Science:
- Nephrology
- Clinical Practice Guidelines
- Health Technology Assessment
Background:
- Two conflicting guidelines from France's Haute autorité de santé (HAS) exist regarding vitamin D testing in chronic kidney disease (CKD).
- The 2012 guideline recommended annual vitamin D testing for all CKD patients.
- The 2013 guideline restricted this testing to post-kidney transplant ambulatory follow-up.
Purpose of the Study:
- To evaluate the methodological quality of the 2012 and 2013 HAS guidelines.
- To compare the development rigor and editorial independence of both guidelines using the AGREE instrument.
Main Methods:
- Comparative evaluation of two clinical practice guidelines using the Appraisal of Guidelines for Research and Evaluation (AGREE) instrument.
- Analysis focused on guideline development rigor (domain 3) and editorial independence (domain 6).
Main Results:
- The 2013 guideline scored higher in development rigor (57%) and editorial independence (56%) compared to the 2012 guideline (24% and 25%, respectively).
- Despite higher scores, the AGREE tool's subjective value and identified shortcomings in both guidelines raise concerns.
Conclusions:
- The methods used to develop both HAS guidelines are deemed too uncertain for unconditional use, particularly the 2012 guideline.
- Recommendations from the 2013 guideline may hold higher validity due to more rigorous development, but caution is still advised.
Abstract:
Two clinical practice guidelines published in 2012 and in 2013 by the Haute autorité de santé (HAS) respectively entitled "Adult chronic kidney disease" (clinical pathway guidelines) and "Clinical utility of vitamin D measurements" (Health technology assessment) contradict each other on a notable point: in 2012 the HAS recommend to measure blood concentrations of vitamin D once a year in all patients with chronic kidney disease whereas in 2013 the HAS recommend to use this test only for the ambulatory follow-up of patients three months after kidney transplantation. This contradiction encouraged us to evaluate the methodological quality of these two guidelines with the help of the AGREE (Appraisal of Guidelines for Research and Evaluation) instrument which is consensual at an international level, in particular at the WHO (World Health Organization) and at the European Union. At the end of this comparative evaluation this preliminary hypothesis might be proposed: a more rigorous development (AGREE domain n̊3) as well as a higher editorial independence (AGREE domain n̊6) in 2013 than in 2012 (scores respectively are 57% and 56% in 2013 versus 24% and 25% in 2012) ensure a higher validity to the 2013 recommendations than to the 2012 recommendations. However this hypothesis is weakened by the subjective intrinsic value of the AGREE tool, and by various methodological shortcomings in these two guidelines. Therefore we conclude, using the AGREE terminology, that the methods for developing those guidelines are too uncertain, above all in 2012, for recommending their use without modifications.
Related Concept Videos
Guidelines For Measuring Vital Signs
Before taking a patient's vital signs, a nurse would consider and assess the patient's comfort level and ensure appropriate equipment is available.
Pre-Procedural Guidelines for Assessing Blood Pressure
Guidelines for Nursing Documentation II
Timely documentation is crucial to ensure continuity of care for patients. Any delays in recording or reporting medical information can result in medical errors and even adverse patient outcomes. From medication administration to diagnostic test results, every detail must be accurately and promptly documented to provide the best possible care for patients.
Standards of Care I
Standards of Care II
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...